BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36344272)

  • 1.
    Palaiodimou L; Stefanou MI; Bakola E; Papadopoulou M; Kokotis P; Vrettou AR; Kapsia E; Petras D; Anastasakis A; Xifaras N; Karachaliou E; Touloumi G; Vlachopoulos C; Boletis IN; Giannopoulos S; Tsivgoulis G; Zompola C
    Neurology; 2022 Nov; 99(19):e2188-e2200. PubMed ID: 36344272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabry disease due to D313Y and novel GLA mutations.
    Koulousios K; Stylianou K; Pateinakis P; Zamanakou M; Loules G; Manou E; Kyriklidou P; Katsinas C; Ouzouni A; Kyriazis J; Speletas M; Germenis AE
    BMJ Open; 2017 Oct; 7(10):e017098. PubMed ID: 28988177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the alpha-galactosidase A variant p.Asp313Tyr (p.D313Y) pathogenic for Fabry disease? A systematic review.
    Effraimidis G; Rasmussen ÅK; Bundgaard H; Sørensen SS; Feldt-Rasmussen U
    J Inherit Metab Dis; 2020 Sep; 43(5):922-933. PubMed ID: 32246457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mutation p.D313Y is associated with organ manifestation in Fabry disease.
    du Moulin M; Koehn AF; Golsari A; Dulz S; Atiskova Y; Patten M; Münch J; Avanesov M; Ullrich K; Muschol N
    Clin Genet; 2017 Nov; 92(5):528-533. PubMed ID: 28276057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of
    Monda E; Diana G; Graziani F; Rubino M; Bakalakos A; Linhart A; Germain DP; Scarpa M; Biagini E; Pieroni M; Elliott PM; Limongelli G
    Circ Genom Precis Med; 2023 Dec; 16(6):e004252. PubMed ID: 38047356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D313Y variant in two related end-stage renal disease patients - Pathogenic or not yet?
    Vicente R; Santos I; Coimbra M; Santos J; Santos R; Amoedo M; Pires C
    Nefrologia (Engl Ed); 2023; 43(5):636-639. PubMed ID: 36517364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The D313Y variant in the GLA gene - no evidence of a pathogenic role in Fabry disease.
    Hasholt L; Ballegaard M; Bundgaard H; Christiansen M; Law I; Lund AM; Norremolle A; Krogh Rasmussen A; Ravn K; Tumer Z; Wibrand F; Feldt-Rasmussen U
    Scand J Clin Lab Invest; 2017 Dec; 77(8):617-621. PubMed ID: 29037082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y.
    Oder D; Üçeyler N; Liu D; Hu K; Petritsch B; Sommer C; Ertl G; Wanner C; Nordbeck P
    BMJ Open; 2016 Apr; 6(4):e010422. PubMed ID: 27059467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationwide screening for Fabry disease in unselected stroke patients.
    Tomek A; Petra R; Paulasová Schwabová J; Olšerová A; Škorňa M; Nevšímalová M; Šimůnek L; Herzig R; Fafejtová Š; Mikulenka P; Táboříková A; Neumann J; Brzezny R; Sobolová H; Bartoník J; Václavík D; Vachová M; Bechyně K; Havlíková H; Prax T; Šaňák D; Černíková I; Ondečková I; Procházka P; Rajner J; Škoda M; Novák J; Škoda O; Bar M; Mikulík R; Dostálová G; Linhart A;
    PLoS One; 2021; 16(12):e0260601. PubMed ID: 34905550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dorsal root ganglia volume is increased in patients with the Fabry-related GLA variant p.D313Y.
    Godel T; Bäumer P; Stumpfe K; Muschol N; Kronlage M; Brunnée M; Kollmer J; Heiland S; Bendszus M; Mautner VF
    J Neurol; 2019 Jun; 266(6):1332-1339. PubMed ID: 30830284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of Fabry disease in male and female haemodialysis patients in Spain.
    Gaspar P; Herrera J; Rodrigues D; Cerezo S; Delgado R; Andrade CF; Forascepi R; Macias J; del Pino MD; Prados MD; de Alegria PR; Torres G; Vidau P; Sá-Miranda MC
    BMC Med Genet; 2010 Feb; 11():19. PubMed ID: 20122163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Fabry Disease in Familial Mediterranean Fever Patients from Central Anatolia of Turkey.
    Huzmeli C; Candan F; Alaygut D; Bagci G; Akkaya L; Bagci B; Sozmen EY; Kurtulgan HK; Kayatas M
    Biochem Genet; 2016 Aug; 54(4):448-456. PubMed ID: 27105876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant.
    Lenders M; Weidemann F; Kurschat C; Canaan-Kühl S; Duning T; Stypmann J; Schmitz B; Reiermann S; Krämer J; Blaschke D; Wanner C; Brand SM; Brand E
    Orphanet J Rare Dis; 2016 May; 11(1):54. PubMed ID: 27142856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young.
    De Brabander I; Yperzeele L; Ceuterick-De Groote C; Brouns R; Baker R; Belachew S; Delbecq J; De Keulenaer G; Dethy S; Eyskens F; Fumal A; Hemelsoet D; Hughes D; Jeangette S; Nuytten D; Redondo P; Sadzot B; Sindic C; Sheorajpanday R; Thijs V; Van Broeckhoven C; De Deyn PP
    Clin Neurol Neurosurg; 2013 Jul; 115(7):1088-93. PubMed ID: 23219219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Later Onset Fabry Disease, Cardiac Damage Progress in Silence: Experience With a Highly Prevalent Mutation.
    Hsu TR; Hung SC; Chang FP; Yu WC; Sung SH; Hsu CL; Dzhagalov I; Yang CF; Chu TH; Lee HJ; Lu YH; Chang SK; Liao HC; Lin HY; Liao TC; Lee PC; Li HY; Yang AH; Ho HC; Chiang CC; Lin CY; Desnick RJ; Niu DM
    J Am Coll Cardiol; 2016 Dec; 68(23):2554-2563. PubMed ID: 27931613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher rate of rheumatic manifestations and delay in diagnosis in Brazilian Fabry disease patients.
    Rosa Neto NS; Bento JCB; Pereira RMR
    Adv Rheumatol; 2020 Jan; 60(1):7. PubMed ID: 31907047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and Management of Fabry Disease in High-Risk Renal Disease Patients in Taiwan: A Single Center Study.
    Shih CY; You ZH; Tsai SF; Wu MJ; Yu TM; Chuang YW; Chen CH
    Transplant Proc; 2023 May; 55(4):788-791. PubMed ID: 37230899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabry disease screening in high-risk populations in Japan: a nationwide study.
    Yoshida S; Kido J; Sawada T; Momosaki K; Sugawara K; Matsumoto S; Endo F; Nakamura K
    Orphanet J Rare Dis; 2020 Aug; 15(1):220. PubMed ID: 32843101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabry disease caused by the GLA p.Phe113Leu (p.F113L) variant: Natural history in males.
    Oliveira JP; Nowak A; Barbey F; Torres M; Nunes JP; Teixeira-E-Costa F; Carvalho F; Sampaio S; Tavares I; Pereira O; Soares AL; Carmona C; Cardoso MT; Jurca-Simina IE; Spada M; Ferreira S; Germain DP
    Eur J Med Genet; 2020 Feb; 63(2):103703. PubMed ID: 31200018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, histological and molecular characteristics of Mexican patients with Fabry disease and significant renal involvement.
    Ramos-Kuri M; Olvera D; Morales JJ; Rodriguez-Espino BA; Lara-Mejía A; De Los Ríos D; Obrador GT; Granados J; Correa-Rotter R
    Arch Med Res; 2014 Apr; 45(3):257-62. PubMed ID: 24656905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.